Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Roberta Loveikyte"'
Autor:
Andrea E van der Meulen-de Jong, Gerard Dijkstra, Zlatan Mujagic, Marjolijn Duijvestein, Rogier L Goetgebuer, Roberta Loveikyte
Publikováno v:
BMJ Open, Vol 14, Iss 1 (2024)
Introduction Iron deficiency anaemia (IDA) is the most common systemic manifestation of inflammatory bowel disease (IBD) that has detrimental effects on quality of life (QoL) and disease outcomes. Iron deficiency (ID), with or without anaemia, poses
Externí odkaz:
https://doaj.org/article/469e9e2b6da24ccbae0dd7ae26c3e242
Autor:
Marta S. Alexdottir, Arno R. Bourgonje, Morten A. Karsdal, Martin Pehrsson, Roberta Loveikyte, Hendrik M. van Dullemen, Marijn C. Visschedijk, Eleonora A. M. Festen, Rinse K. Weersma, Klaas Nico Faber, Gerard Dijkstra, Joachim H. Mortensen
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
BackgroundCrohn’s disease (CD) is characterized by excessive protease activity and extracellular matrix (ECM) remodeling. To date, 30–50% of patients experience non-response to anti-TNF-α treatment. This study aimed to assess whether serological
Externí odkaz:
https://doaj.org/article/fff2a2308066439c9000ede3fd3ae70f
Autor:
Marta S. Alexdottir, Arno R. Bourgonje, Morten A. Karsdal, Martin Pehrsson, Roberta Loveikyte, Hendrik M. van Dullemen, Marijn C. Visschedijk, Eleonora A. M. Festen, Rinse K. Weersma, Klaas Nico Faber, Gerard Dijkstra, Joachim H. Mortensen
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 15, p 8137 (2022)
Crohn’s disease (CD) is a relapsing-remitting inflammatory disease of the gastrointestinal (GI) tract characterized by increased extracellular matrix (ECM) remodeling. The introduction of the α4β7-integrin inhibitor vedolizumab (VEDO) has improve
Externí odkaz:
https://doaj.org/article/86aec7cd862f4bb7a5aa85eb0a5b04aa
Autor:
Arno R. Bourgonje, Marta S. Alexdottir, Antonius T. Otten, Roberta Loveikyte, Anne‐Christine Bay‐Jensen, Martin Pehrsson, Hendrik M. van Dullemen, Marijn C. Visschedijk, Eleonora A. M. Festen, Rinse K. Weersma, Morten A. Karsdal, Klaas Nico Faber, Joachim H. Mortensen, Gerard Dijkstra
Publikováno v:
Alimentary Pharmacology & Therapeutics, 56(4), 675-693. Wiley
Background: Increased collagen remodelling is a key pathophysiological component underlying intestinal stricture and fistula development in Crohn's disease (CD).Aims: To investigate associations between serological biomarkers of collagen turnover and
Autor:
Marta Sorokina Alexdóttir, Arno R. Bourgonje, Morten Asser Karsdal, Anne-Christine Bay-Jensen, Martin Pehrsson, Roberta Loveikyte, Hendrik M. Van Dullemen, Marijn C. Visschedijk, Eleonora A. Festen, Rinse K. Weersma, Klaas Nico Faber, Gerard Dijkstra, Joachim Høg Mortensen
Publikováno v:
Gastroenterology. 162:S-803
Autor:
Marta Sorokina Alexdóttir, Arno R. Bourgonje, Morten Asser Karsdal, Anne-Christine Bay-Jensen, Martin Pehrsson, Roberta Loveikyte, Hendrik M. Van Dullemen, Marijn C. Visschedijk, Eleonora A. Festen, Rinse K. Weersma, Klaas Nico Faber, Gerard Dijkstra, Joachim Høg Mortensen
Publikováno v:
Gastroenterology. 162:S-802
Autor:
Arno R. Bourgonje, Marta Sorokina Alexdóttir, Roberta Loveikyte, Martin Pehrsson, Anne-Christine Bay-Jensen, Hendrik M. Van Dullemen, Marijn C. Visschedijk, Eleonora A. Festen, Rinse K. Weersma, Morten Asser Karsdal, Klaas Nico Faber, Joachim H⊘g Mortensen, Gerard Dijkstra
Publikováno v:
Gastroenterology. 162:S-614
Autor:
Marijn C. Visschedijk, Arno R. Bourgonje, Marta S. Alexdóttir, Hendrik M. van Dullemen, Rinse K. Weersma, Morten A. Karsdal, Anne-Christine Bay-Jensen, Eleonora A. M. Festen, Roberta Loveikyte, Gerard Dijkstra, Klaas Nico Faber, Joachim Høg Mortensen
Publikováno v:
Journal of Crohn's and Colitis. 15:S453-S454
Background Crohn’s disease (CD) is a relapsing-remitting inflammatory disease of the gastrointestinal (GI) tract characterized by high protease activity and increased extracellular matrix (ECM) turnover. Although immunotherapeutic drugs such as ant
Autor:
Klaas Nico Faber, Joachim Høg Mortensen, Hendrik M. van Dullemen, Marta S. Alexdóttir, Marijn C. Visschedijk, Anne-Christine Bay-Jensen, Roberta Loveikyte, Gerard Dijkstra, Eleonora A. M. Festen, Morten A. Karsdal, Rinse K. Weersma, Arno R. Bourgonje
Publikováno v:
Journal of Crohn's and Colitis. 15:S309-S310
Background Up to 50% of patients with ulcerative colitis (UC) do not respond to biological therapies, including TNF-α-antagonists (e.g., infliximab, IFX) and migration inhibitors (e.g., the α4β7-integrin inhibitor vedolizumab, VEDO). Therefore, se
Autor:
Marijn C. Visschedijk, Rinse K. Weersma, Hendrik M. van Dullemen, Morten A. Karsdal, Marta S. Alexdóttir, Arno R. Bourgonje, Eleonora A. M. Festen, Anne-Christine Bay-Jensen, Klaas Nico Faber, Joachim Høg Mortensen, Roberta Loveikyte, Gerard Dijkstra
Publikováno v:
Journal of Crohn's and Colitis. 15:S214-S215
Background Crohn’s disease (CD) is characterized by increased extracellular matrix (ECM) remodeling, which is a key pathophysiological mechanism underlying intestinal stricture formation and other fibrotic disease complications. Alterations in inte